| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.03 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.084 | 0.04 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.41 | 0.04 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |